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Background: The impact of bleeding on the long-term clinical outcomes after drug-eluting stent (DES) implantation in real world practice is not 
known well.
Methods: A consecutive 3,170 patients (mean age of 60.4±10.3 years) receiving DES between February 2003 and March 2006 were enrolled. To 
assess the clinical impact of bleeding on the long-term risk of adverse outcomes, such as cardiac mortality, myocardial infarction (MI), target lesion 
revascularization (TLR) and stent thrombosis (ST), we created the multivariate Cox-models adjusting baseline covariates. Bleeding complication was 
defined as the occurrence of major bleeding according to the STEEPLE criteria .
Results: The incidence of bleeding complication was 1.8% during the median follow-up of 1,366 days (interquartile range: 1,106-1,590), which 
was censored at the fixed time of 1,095 days. In Log-rank analyses, patients with bleeding has higher incidence of cardiac mortality (18.3 vs.1.7%, 
p<0.001), MI (7.9 vs.1.2%, p<0.001), TLR (22.9 vs. 5.6, p<0.001), and definite ST (8.6 vs. 0.7%, p<0.001) than those without bleeding. Adjusted 
hazard ratios (HRs) and their confidence intervals (CIs) were presented in the Figure.
Conclusions: After DES implantation in the real world practice, bleeding complication was independently associated with the long-term adverse 
clinical outcomes. Therefore, an episode of major bleeding should be carefully monitored as one of the important long-term clinical outcomes.
